相关实验视频
Updated: Jul 25, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.7K
doxorubicin 介导的心脏功能障碍:重温分子相互作用,药理学化合物和 (纳米) 疗效平台
1Department of Emergency, Shanghai Tenth People's Hospital, School of Medicine Tongji University, Shanghai, 200072, China.
Environmental research
|June 25, 2023
概括
多克索鲁比 (DOX) 化学疗法通过各种途径引起心脏损伤. 涉及保护机制,药物和纳米疗法的策略可以减轻与DOX相关的心脏毒性和心血管疾病.
科学领域:
- 心血管药理学心血管药理学
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
背景情况:
- doxorubicin (DOX) 是固体和血液瘤的重要化疗剂,但其使用受到度依赖心脏毒性的限制.
- DOX诱导的心脏功能障碍源于亡,铁亡,氧化应激和炎症,显著影响患者的生活质量.
研究的目的:
- 综合审查多克索鲁比中介性心脏毒性机制.
- 探索治疗策略,以减轻DOX诱导的心脏损伤和预防心血管疾病.
主要方法:
- 对多克索鲁比对心脏功能影响的文献综述.
- 保护途径,药理干预和纳米治疗方法的分析.
主要成果:
- 暴露于DOX会触发亡和铁亡,导致心脏功能障碍和心血管疾病的风险增加.
- 像Nrf2这样的保护机制可以抵消DOX的毒性.
- 药理剂和纳米平台在减少DOX副作用和心脏毒性方面表现有前途.
结论:
- 通过DOX介导的心脏毒性是一个重大的临床挑战.
- 针对保护性途径和利用先进的药物输送系统,如纳米疗法,对于管理DOX副作用至关重要.
- 这些策略可以改善接受化疗的癌症患者的心血管健康.
相关概念视频
Heart Failure Drugs: Inotropic Agents
640
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
640
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16

